News - Anti-Arthritics/Rheumatics, sarilumab

Filter

Popular Filters

Sanofi and Regeneron report positive Phase III results with sarilumab in RA

Sanofi and Regeneron report positive Phase III results with sarilumab in RA

22-11-2013

French drug major Sanofi (Euronext: SAN) and US partner Regeneron Pharmaceuticals (Nasdaq: REGN) have…

Anti-Arthritics/RheumaticsEuropeNorth AmericaPharmaceuticalRegeneronResearchSanofisarilumabUSA

Bayer initiates Ph III Stivarga study in liver cancer; Sanofi enrolls sarilumab patients

15-05-2013

German drug major Bayer (BAYN: DE) says that patient enrollment is underway for RESORCE (Regorafenib…

Anti-Arthritics/RheumaticsBayerOncologyPharmaceuticalRegeneronResearchSanofisarilumabStivarga

Back to top